A detailed history of Intrepid Family Office LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Intrepid Family Office LLC holds 25,000 shares of ORGO stock, worth $88,750. This represents 0.13% of its overall portfolio holdings.

Number of Shares
25,000
Previous 110,000 77.27%
Holding current value
$88,750
Previous $365,000 78.36%
% of portfolio
0.13%
Previous 0.69%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$2.34 - $4.43 $23,400 - $44,300
-10,000 Reduced 9.09%
100,000 $318,000
Q2 2023

Aug 14, 2023

BUY
$1.9 - $4.3 $133,000 - $301,000
70,000 Added 175.0%
110,000 $365,000
Q4 2022

Feb 14, 2023

BUY
$2.48 - $3.43 $12,400 - $17,150
5,000 Added 14.29%
40,000 $107,000
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $109,900 - $225,050
35,000 New
35,000 $113,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $465M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Intrepid Family Office LLC Portfolio

Follow Intrepid Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Family Office LLC with notifications on news.